tiprankstipranks
CASI Pharmaceuticals (CASIF)
OTHER OTC:CASIF
US Market
CASIF
CASI Pharmaceuticals
RESEARCH TOOLSreports
Want to see CASIF full AI Analyst Report?

CASI Pharmaceuticals (CASIF) Financial Statements

478 Followers

CASI Pharmaceuticals Financial Overview

CASI Pharmaceuticals's market cap is currently $2.32M. The company's EPS TTM is $; its P/E ratio is -0.61; CASI Pharmaceuticals is scheduled to report earnings on April 29, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 25Dec 23Mar 23Dec 21Dec 20
Income Statement
Total Revenue$ 28.54M$ 33.88M$ 43.11M$ 30.17M$ 15.14M
Gross Profit$ 11.15M$ 20.05M$ 27.28M$ 17.61M$ 5.63M
Operating Income$ -39.62M$ -25.08M$ -26.49M$ -41.52M$ -52.78M
EBITDA$ -34.87M$ -21.54M$ -24.07M$ -33.40M$ -31.35M
Net Income$ -39.26M$ -26.94M$ -41.01M$ -36.65M$ -48.29M
Balance Sheet
Cash & Short-Term Investments$ 16.09M$ 30.77M$ 51.34M$ 48.57M$ 66.37M
Total Assets$ 53.67M$ 75.27M$ 96.23M$ 138.30M$ 127.73M
Total Debt$ 22.14M$ 21.24M$ 1.34M$ 4.33M$ 3.20M
Net Debt$ 8.67M$ 4.16M$ -45.77M$ -34.37M$ -53.87M
Total Liabilities$ 51.82M$ 51.10M$ 29.30M$ 30.34M$ 24.16M
Stockholders' Equity$ 1.85M$ 24.16M$ 44.57M$ 84.50M$ 81.54M
Cash Flow
Free Cash Flow$ -29.46M$ -22.21M$ -26.70M$ -42.34M$ -45.21M
Operating Cash Flow$ -29.22M$ -19.97M$ -21.09M$ -26.84M$ -25.89M
Investing Cash Flow$ 11.24M$ -9.67M$ 31.16M$ -20.69M$ -20.72M
Financing Cash Flow$ 15.43M$ -907.00K$ -3.27M$ 29.64M$ 47.15M
Currency in USD

CASI Pharmaceuticals Earnings and Revenue History

Income Statement >

CASI Pharmaceuticals Debt to Assets

Balance Sheet >

CASI Pharmaceuticals Cash Flow

Cash Flow >

CASI Pharmaceuticals Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
Earnings >